Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
At 24 weeks, retatrutide 12 mg delivers 17.5% body weight loss versus an estimated 12-13% for tirzepatide 15 mg
Our team generally advises against this practice
Individual responses to GLP-1 therapy are influenced by baseline health status, concurrent medications, dietary habits, and lifestyle factors
Scale numbers falling off a cliff
Weight loss effects of GLP-1RAs Liraglutide (3.0 mg, Saxenda), a GLP-1RA that activates the GLP-1 receptor, was approved by the FDA in December 2014 for adult obesity treatment [38] and has recently shown efficacy in adolescents aged 12 to 18 years
Mounjaro (tirzepatide) activates two receptors: the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor
US$ 22.23
US$ 22.76
US$ 29.70
US$ 29.67
US$ 22.27
